GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NLS Pharmaceutics Ltd (NAS:NLSP) » Definitions » Machinery, Furniture, Equipment

NLSP (NLS Pharmaceutics) Machinery, Furniture, Equipment : $0.04 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is NLS Pharmaceutics Machinery, Furniture, Equipment?

NLS Pharmaceutics's Machinery, Furniture, Equipment for the quarter that ended in Dec. 2024 was $0.04 Mil.

NLS Pharmaceutics's quarterly Machinery, Furniture, Equipment declined from Dec. 2023 ($0.04 Mil) to Jun. 2024 ($0.00 Mil) but then increased from Jun. 2024 ($0.00 Mil) to Dec. 2024 ($0.04 Mil).

NLS Pharmaceutics's annual Machinery, Furniture, Equipment stayed the same from Dec. 2022 ($0.04 Mil) to Dec. 2023 ($0.04 Mil) but then increased from Dec. 2023 ($0.04 Mil) to Dec. 2024 ($0.04 Mil).

NLS Pharmaceutics Machinery, Furniture, Equipment Historical Data

The historical data trend for NLS Pharmaceutics's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NLS Pharmaceutics Machinery, Furniture, Equipment Chart

NLS Pharmaceutics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Machinery, Furniture, Equipment
Get a 7-Day Free Trial - 0.04 0.04 0.04 0.04

NLS Pharmaceutics Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Machinery, Furniture, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.04 0.04 - 0.04

NLS Pharmaceutics Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

NLS Pharmaceutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NLS Pharmaceutics Ltd (NAS:NLSP) » Definitions » Machinery, Furniture, Equipment
Comparable Companies
PHIO BTAI BCLI APLM CARM TSBX GNPX SLXN GTBP SNSE VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
The Circle 6, Zurich, CHE, 8058
Website
https://www.nlspharma.com
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.